Leptin, polycystic ovaries and polycystic ovary syndrome

Human Reproduction Update

Volumn 5, Issue 2, 1999, Pages 166-171

  Jacobs, H S ^a   Conway, G S ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Insulin resistance; Leptin; Obesity; Polycystic ovary syndrome

Indexed keywords

INSULIN; LEPTIN; NEUROPEPTIDE Y;

FEMALE; HUMAN; INSULIN RESISTANCE; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; REVIEW;

FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; NEUROPEPTIDE Y; OBESITY; OVARY; POLYCYSTIC OVARY SYNDROME; PROTEINS;

EID: 0032903024     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/5.2.166     Document Type: Review

References (70)

1. Amiel, S.A., Caprio, S., Sherwin, R.S. et al. (1991) Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. J. Clin. Endocrinol. Metab., 72, 277-282.
2. Antczak, M. and Van Blerkdom, J. (1997) Oocyte influences on early development: the regulatory proteins leptin and STAT3 are polarized in mouse and human oocytes and differentially distributed within the cell of the preimplantation stage embryo. Mol. Hum. Reprod., 3, 1067-1086.
3. Apter, D., Butzow, T., Laughlin, G.A. and Yen, S.S. (1995) Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. J. Clin. Endocrinol. Metab., 80, 2966-2973.
4. Arroyo, A., Laughlin, G.A., Morales, A.J. and Yen, S.S. (1997) Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity. J. Clin. Endocrinol. Metab., 82, 3728-3733.
5. Balen, A.H., Conway, G.S., Kaltsas, G. et al. (1995) Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum. Reprod., 10, 2107-2111.
6. Barash, I.A., Cheung, C.C., Weigle, D.S. et al. (1996) Leptin is a metabolic signal to the reproductive system. Endocrinology, 137, 3144-3147.
7. Bjorntorp, P. (1996) The android woman - a risky condition. J. Intern. Med., 239, 105-110.
8. Bray, G.A. and York, D.A. (1997) Clinical review 90. Leptin and clinical medicine: a new piece in the puzzle of obesity. J. Clin. Endocrinol. Metab., 82, 2771-2776.
9. Brzechffa, P.R., Jakimiuk, A.J., Agarwal, S.K. et al. (1996) Serum immunoreactive leptin concentrations in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 81, 4166-4169.
10. Caro, J.F. (1997) Leptin is normal in PCOS; an editorial about three 'negative' papers. J. Clin. Endocrinol. Metab., 82, 1685-1686.
11. Chapman, I.M., Wittert, G.A. and Norman, R.J. (1997) Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters. Clin. Endocrinol., 46, 175-181.
12. Chehab, F.F., Lim, M.E. and Lu, R. (1996) Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nature Genet., 12, 318-320.
13. Chua, S.C.J., Chung, W.K., Wu-Peng, X.S. et al. (1996) Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science, 271, 994-996.
14. Ciaraldi, T.P., Morales, A.J., Hickman, M.G. et al. (1997) Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity. J. Clin. Endocrinol. Metab., 82, 1421-1425.
15. Cioffi, J.A., Shafer, A.W., Zupancic, T.J. et al. (1996) Novel B219/OB receptor isoforms: possible role of leptin in hematopoiesis and reproduction. Nature Med., 2, 585-589.
16. Cioffi, J.A., Van Blerkom, J., Antczak, M. et al. (1997) The expression of leptin and its receptors in pre-ovulatory human follicles. Mol. Hum. Reprod., 3, 467-472.
17. Clement, K., Vaisse, C., Lahlou, N. et al. (1998) A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature, 392, 398-401.
18. Cohen, B., Novick, D. and Rubenstein, M. (1996) Modulation of insulin activities by leptin. Science, 274, 1185-1188.
19. Conn, J.J. and Jacobs, H.S. (1997) The clinical management of hirsutism (review). Eur. J. Endocrinol., 136, 339-348.
20. Considine, R.V., Sinha, M.K., Heiman, M.L. et al. (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med., 334, 292-295.
21. Conway, G.S. and Jacobs, H.S. (1990) Acanthosis nigricans in obese women with the polycystic ovary syndrome: disease spectrum not distinct entity. Postgrad. Med. J., 66, 536-538.
22. Conway, G.S. and Jacobs, H.S. (1993) Clinical implications of hyperinsulinaemia in women. Clin. Endocrinol., 39, 623-632.
23. Conway, G.S. and Jacobs, H.S. (1997) Leptin: a hormone of reproduction. Hum. Reprod., 12, 633-635.
24. Conway, G.S., Jacobs, H.S., Holly, J.M. and Wass, J.A. (1990) Effects of luteinizing hormone, insulin, insulin-like growth factor-I and insulin-like growth factor small binding protein 1 in the polycystic ovary syndrome. Clin. Endocrinol., 33, 593-603.
25. Dahlgren, E., Johansson, S., Lindstedt, G. et al. (1992) Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil. Steril., 57, 505-513.
26. Dunaif, A. (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr. Rev., 18, 774-800.
27. Dunaif, A., Segal, K.R., Futterweit, W. and Dobrjansky, A. (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 38, 1165-1174.
28. Dunaif, A., Xia, J., Book, C.B. et al. (1995) Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J. Clin. Invest., 96, 801-810.
29. Dunaif, A., Scott, D., Finegood, D. et al. (1996) The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 81, 3299-3306.
30. Erickson, J.C., Ahima, R.S., Hollopeter, G. et al. (1997) Endocrine function of neuropeptide Y knockout mice. Regulatory Peptides, 70, 199-202.
31. Franks, S. (1995) Polycystic ovary syndrome. N. Engl. J. Med., 333, 853-861.
32. Friedman, J.M. (1998) The alphabet of weight control. Nature, 385, 119-120.
33. Halaas, J.L. and Friedman, J.M. (1997) Leptin and its receptor. J. Endocrinol., 155, 215-216.
34. Havel, P.J., Kasim-Karakas, S., Dubuc, G.R. et al. (1996) Gender differences in plasma leptin concentrations. Nature Med., 2, 949-950.
35. Houseknecht, K.L., Mantzoros, C.S., Kuliawat, R. et al. (1996) Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity. Diabetes, 45, 1638-1643.
36. Hube, F., Lietz, U., Igel, M. et al. (1996) Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans. Horm. Metab. Res., 28, 690-693.
37. Jacobs, H.S. (1987) Polycystic ovaries and polycystic ovary syndrome. Gynecol. Endocrinol., 1, 113-131.
38. Jahanfar, S., Eden, J.A. and Nguyen, T.V. (1995) Bulimia nervosa and polycystic ovary syndrome. Gynecol. Endocrinol., 9, 113-117.
39. Karlsson, C., Lindell, K., Svensson, E. et al. (1997) Expression of functional leptin receptors in the human ovary. J. Clin. Endocrinol. Metab., 82, 4144-4148.
40. Kiddy, D.S., Hamilton-Fairley, D., Bush, A. et al. (1992) Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin. Endocrinol., 36, 105-111.
41. Kotani, K., Tokunaga, K., Fujioka, S. et al. (1994) Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int. J. Obes. Related Metab. Disorders, 18, 202-207.
42. Krassas, G.E., Kaltsas, T.H., Pontikedes, N. et al. (1998) Leptin levels in women with polycystic ovary syndrome before and after treatment with diazoxide. Eur. J. Endocrinol., 139, 184-189.
43. Laughlin, G.A., Morales, A.J. and Yen, S.S. (1997) Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia. J. Clin. Endocrinol. Metab., 82, 1692-1696.
44. Mantzoros, C.S., Dunaif, A. and Flier, J.S. (1997) Leptin concentrations in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 82, 1687-1691.
45. McCluskey, S., Evans, C., Lacey, J.H. et al. (1991) Polycystic ovary syndrome and bulimia. Fertil. Steril., 55, 287-291.
46. Micic, D., Macut, D., Popovic, V. et al. (1997) Leptin levels and insulin sensitivity in obese and non-obese patients with polycystic ovary syndrome. Gynecol. Endocrinol., 11, 315-320.
47. Neel, J.V. (1962) Diabetes mellitus: a 'thrifty' genotype rendered detrimental by 'progress'. Am. J. Hum. Genet., 14, 353-362.
48. Nestler, J.E. (1997) Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications. Semin. Reprod. Endocrinol., 15, 111-122.
49. Nestler, J.E., Barlascini, C.O., Matt, D.W. et al. (1989) Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 68, 1027-1032.
50. Nestler, J.E., Jakubowicz, D.J., Evans, W.S. and Pasquali, R. (1998) Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N. Engl. J. Med., 338, 1876-1880.
51. Pelleymounter, M.A., Cullen, M.J., Baker, M.B. et al. (1995) Effects of the obese gene product on body weight regulation in ob/ob mice. Science, 269, 540-543.
52. Pierpoint, T., McKeigue, P.M., Isaacs, A.J. et al. (1998) Mortality of women with polycystic ovary syndrome at long-term follow-up. J. Clin. Epidemiol., 51, 581-586.
53. Porcu, E., Venturoli, S., Longhi, M. et al. (1997) Chronobiologic evolution of luteinizing hormone secretion in adolescence: developmental patterns and speculations on the onset of the polycystic ovary syndrome. Fertil. Steril., 67, 842-848.
54. Ravussin, E., Pratley, R.E., Maffei, M. et al. (1997) Relatively low plasma leptin concentrations precede weight gain in Pima Indians. Nature Med., 3, 238-240.
55. Rohner-Jeanrenaud, F. and Jeanrenaud, B. (1996) Obesity, leptin and the brain. N. Engl. J. Med., 334, 324-325.
56. Rosenbaum, M., Nicolson, M., Hirsch, J. et al. (1996) Effects of gender, body composition, and menopause on plasma concentrations of leptin. J. Clin. Endocrinol Metab., 81, 3424-3427.
57. Rouru, J., Anttila, L., Koskinen, P. et al. (1997) Serum leptin concentrations in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 82, 1697-1700.
58. Saladin, R., De Vos, P., Guerre-Millo, M. et al. (1995) Transient increase in obese gene expression after food intake or insulin administration. Nature, 377, 527-529.
59. Sharma, S. and Jacobs, H.S. (1997) Polycystic ovary syndrome associated with treatment with the anticonvulsant sodium valproate. Curr. Opin. Obstet. Gynecol., 9, 391-392.
60. Sierra-Honigmann, M.R., Nath, A.K., Murakami, C. et al. (1998) Biological action of leptin as an angiogenic factor. Science, 281, 1683-1686.
61. Sinha, M.K., Sturis, J., Ohannesian, J. et al. (1996) Ultradian oscillations of leptin secretion in humans. Biochem. Biophys. Res. Commun., 228, 733-738.
62. Stephens, T.W. (1998) Life without neuropeptide Y. Nature, 381, 377-378.
63. Stephens, T.W., Basinski, M., Bristow, P.K. et al. (1995) The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature, 377, 530-532.
64. Strobel, A., Issad, T., Camoin, L. et al. (1998) A leptin missense mutation associated with hypogonadism and morbid obesity. Nature Genet., 18, 213-215.
65. Swerdloff, R.S., Batt, R.A. and Bray, G.A. (1976) Reproductive hormonal function in the genetically obese (ob/ob) mouse. Endocrinology, 98, 1359-1364.
66. Tartaglia, L.A., Dembski, M., Weng, X. et al. (1995) Identification and expression cloning of a leptin receptor, OB-R. Cell, 83, 1263-1271.
67. Wabitsch, M., Blum, W.F., Muche, R. et al. (1997) Contribution of androgens to the gender difference in leptin production in obese children and adolescents. J. Clin. Invest., 100, 808-813.
68. White, D.M., Polson, D.W., Kiddy, D. et al. (1996) Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. J. Clin. Endocrinol. Metab., 81, 3821-3824.
69. Zachow, R.J. and Magoffin, D.A. (1997) Direct intraovarian effects of leptin: impairment of the synergistic action of insulin-like growth factor-I on follicle-stimulating hormone-dependent estradiol-17 beta production by rat ovarian granulosa cells. Endocrinology, 138, 847-850.
70. Zhang, Y., Proenca, R., Maffei, M. et al. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature, 372, 425-432.